MERKEL, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.406
EU - Europa 2.324
AS - Asia 2.010
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
OC - Oceania 4
Totale 21.755
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.386
CN - Cina 1.016
SG - Singapore 722
FI - Finlandia 542
IT - Italia 400
DE - Germania 352
SE - Svezia 308
FR - Francia 258
UA - Ucraina 235
VN - Vietnam 183
GB - Regno Unito 137
IE - Irlanda 41
IN - India 34
TR - Turchia 33
CA - Canada 20
GR - Grecia 19
RO - Romania 8
EU - Europa 6
NL - Olanda 6
BG - Bulgaria 5
TH - Thailandia 5
JP - Giappone 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SI - Slovenia 3
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EG - Egitto 2
PT - Portogallo 2
AT - Austria 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
IR - Iran 1
JO - Giordania 1
LY - Libia 1
NO - Norvegia 1
PH - Filippine 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 21.755
Salva come PNG Salva come JPEG
Città #
Fairfield 2.610
Woodbridge 1.857
Houston 1.644
Ann Arbor 1.410
Chandler 1.343
Jacksonville 1.132
Ashburn 1.068
Wilmington 1.068
Seattle 937
Cambridge 889
Singapore 554
Princeton 531
Medford 287
San Diego 260
Nanjing 224
Dong Ket 180
Beijing 177
Des Moines 163
Helsinki 158
Boardman 148
Roxbury 148
Guangzhou 90
Santa Clara 85
Norwalk 75
Hebei 72
Shenyang 72
Padova 69
Nanchang 66
Changsha 57
Jiaxing 50
Dublin 40
Tianjin 32
Yenibosna 32
Munich 27
Redwood City 27
Rome 27
London 26
Kharkiv 25
New York 19
Jinan 18
Dearborn 12
Ogden 12
Chicago 10
Kunming 10
Borås 9
Hounslow 9
Zhengzhou 9
Falls Church 8
Milan 8
Dallas 7
Genoa 7
Venice 7
Bologna 6
Hangzhou 6
Kilburn 6
Ningbo 6
Ottawa 6
Rockville 6
Taizhou 6
Varese 6
Bari 5
Cesa 5
Florence 5
Lanzhou 5
Los Angeles 5
Mestre 5
Nove 5
Pune 5
Shanghai 5
Sofia 5
Trento 5
Washington 5
Auburn Hills 4
Catania 4
Chengdu 4
Indiana 4
Islington 4
Kuala Lumpur 4
Palermo 4
Paris 4
Pescara 4
Reggio Emilia 4
Sirmione 4
Southwark 4
Taiyuan 4
Toronto 4
Atena Lucana 3
Brindisi 3
Buffalo 3
Chiswick 3
Cornate D'adda 3
Detroit 3
Frankfurt Am Main 3
Fuzhou 3
Islamabad 3
Las Vegas 3
North York 3
Prescot 3
Sarmede 3
Selargius 3
Totale 18.011
Salva come PNG Salva come JPEG
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 189
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 146
The self-morningness/eveningness (Self-ME): An extremely concise and totally subjective assessment of diurnal preference 136
A SIMPLIFIED PSYCHOMETRIC EVALUATION FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 134
Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. 133
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience 128
Nutrition and survival in patients with liver cirrhosis 124
Clinical value of asterixis in 374 well-characterised patients with cirrhosis and varying degree of hepatic encephalopathy 122
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis 121
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! 119
Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis. 118
New abdominal collaterals at ultrasound: A clue of progression of portal hypertension 117
Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout. 116
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 115
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 115
Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. 113
Training of Italian emergency medicine residents in prehospital emergency medicine:state of the art and perspectives of improvement 113
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria 112
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 112
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 110
EVALUATION OF SPLANCHNIC ANGIOGRAPHY AS A PROGNOSTIC INDEX OF SURVIVAL IN PATIENTS WITH CIRRHOSIS 109
Electroencephalography in patients with cirrhosis. 108
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial. 108
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 108
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension 107
Incidence and natural history of small esophageal varices in cirrhotic patients 105
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 103
Encephalopathy or hepatic encephalopathy? 103
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler. 103
Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading. 102
Hepatitis C Virus Reinfection in Liver Transplant Patients: Evaluation of Liver Damage Progression with Echo-Color Doppler 102
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 101
Renal effects of nadolol in cirrhosis. 99
The Influence of Environmental Factors on Sleep Quality in Hospitalized Medical Patients 99
Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: Comparison between acute and chronic effects 98
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 96
Visual attention in cirrhotic patients: a study on covert visual attention orienting. 96
Il timing del trapianto di fegato: Child-Pugh o Mayo score? 96
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 96
Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy 95
A short cut to predict the clinical response to beta-blocker therapy in cirrhosis? 94
Renal haemodynamics in essential hypertension assessed by 133-Xenon washout and selective renal angiography 94
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 94
Prognostic benefit of the addition of an electroencephalographic (EEG) index to the MELD score: the MELD-EEG. 93
Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices 93
Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study 93
Carbon monoxide-mediated activation of a large-conductance calcium-activated potassium channels contrinutes to mesenteric vasodilation in cirrhotic rats. 321 : 187-194. 92
Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG 92
Natural History of cirrhotic patients with small esophageal varices: a prospective study 90
Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis. 90
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. 90
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 90
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. 90
Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. 89
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 89
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery. 88
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 88
Theophylline pharmacokinetics and liver function indexes in chronic liver disease. 88
Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study. 88
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis. 88
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension 86
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 86
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost 85
Attention: Minimal hepatic encephalopathy and road accidents 85
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 85
Sleep-wake abnormalities in patients with cirrhosis. 85
AISF practice guidelines for portal hypertension.Committee for portal hypertension of the Italian Association for the Study of the Liver. 84
PLASMA CARNITINE LEVELS IN LIVER-CIRRHOSIS - RELATIONSHIP WITH NUTRITIONAL-STATUS AND LIVER-DAMAGE 84
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 84
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates 84
Endotoxins and the hepatorenal syndrome. 84
Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosis 83
Bright times for patients with cirrhosis and delayed sleep habits: a case report of the beneficial effect of light therapy 83
Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis 82
The use of human albumin millimicrospheres tagged with 99mTc in the evaluation of the removal capacity of the reticuloendothelial system. 82
Intrarenal blood flow, circulation time, and cortical vascular volume in patients with cirrhosis. 82
Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis. 82
Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma 82
Value of prealbumin plasma levels as liver test. 81
The cirrhotic patient with no varices and with small varices 81
Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. 81
Validation of a predictive model for chronic renal dysfunction following liver transplantation. 81
Malnutrition in alcoholic and virus-related cirrhosis 79
Prognostic indicators of risk for first variceal bleeding in cirrhosis: A multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) Index 79
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. 79
A COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS OF VARICEAL BLEEDING STARTING FROM SMALL ESOPHAGEAL VARICES COMPARED TO SURVEILLANCE AND TREATMENT STARTING FROM LARGE ONES 78
Hypotensive and renal effects of captopril. 78
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 78
Prevention of the formation and growth of esophageal varices 78
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis 78
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. 78
Cirrhosis and muscle cramps: evidence of a causal relationship. 77
Vascularization of experimental liver metastases. 2 - Blood flow. 77
Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. 77
Primary Prophylaxis of Bleeding from Esophageal Varices in Cirrhosis 77
PGE2 urinary escretion and renal haemodynamics after nadolol treatment of portal hypertension in patients with liver cirrhosis. 76
Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler 76
Endoscopic screening for esophageal varices in cirrhotic patients 75
Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis 75
Hepatic venous pressure gradient measurement in clinical hepatology. 75
Totale 9.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.544
article - articoli 59.860
book - libri 629
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.894
Totale 139.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.565 0 0 0 406 458 392 388 509 493 406 279 234
2020/20212.593 123 212 60 195 103 255 71 272 394 253 319 336
2021/20223.553 56 577 371 212 188 169 135 354 207 52 346 886
2022/20232.937 699 244 79 281 495 436 3 186 344 18 112 40
2023/20241.093 63 205 102 85 58 58 33 33 45 23 191 197
2024/20251.043 9 481 323 230 0 0 0 0 0 0 0 0
Totale 21.833